Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.02B |
| 2 |
JPMorgan Chase
JPM
|
+$1.01B |
| 3 |
Equinix
EQIX
|
+$772M |
| 4 |
Wells Fargo
WFC
|
+$700M |
| 5 |
CenterPoint Energy
CNP
|
+$527M |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
+$834M |
| 2 |
Exelon
EXC
|
+$743M |
| 3 |
Fidelity National Information Services
FIS
|
+$736M |
| 4 |
LyondellBasell Industries
LYB
|
+$693M |
| 5 |
PNC Financial Services
PNC
|
+$645M |
Sector Composition
| 1 | Technology | 19.16% |
| 2 | Healthcare | 17.47% |
| 3 | Financials | 14.12% |
| 4 | Industrials | 9.89% |
| 5 | Communication Services | 9.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KRTX
176
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $381M | 0.11% |
1,695,579
+664,845
| +65% | +$150M |
|
177
Moody's
MCO
$91.9B
| $376M | 0.11% |
1,544,428
-398,004
| -20% | -$96.8M |
|
|
ETRN
178
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $367M | 0.11% |
49,137,873
-219,288
| -0.4% | -$1.64M |
|
179
Canadian Natural Resources
CNQ
$64.9B
| $367M | 0.11% |
15,750,794
-1,023,642
| -6% | -$23.8M |
|
180
Amphenol
APH
$145B
| $365M | 0.11% |
10,903,736
+11,022
| +0.1% | +$369K |
|
181
Air Products & Chemicals
APD
$65.2B
| $365M | 0.11% |
1,567,098
-1,008,907
| -39% | -$235M |
|
182
Enbridge
ENB
$107B
| $361M | 0.11% |
9,726,448
-3,730,623
| -28% | -$138M |
|
183
Constellation Brands
STZ
$24.6B
| $354M | 0.1% |
1,540,611
+100,703
| +7% | +$23.1M |
|
184
Iridium Communications
IRDM
$1.89B
| $349M | 0.1% |
7,870,928
+761
| +0% | +$33.8K |
|
185
CRISPR Therapeutics
CRSP
$5.12B
| $349M | 0.1% |
5,342,418
+678,464
| +15% | +$44.3M |
|
186
British American Tobacco
BTI
$123B
| $341M | 0.1% |
9,536,992
-22,485
| -0.2% | -$803K |
|
187
AB InBev
BUD
$114B
| $334M | 0.1% |
7,390,734
+7,980
| +0.1% | +$361K |
|
188
Corteva
CTVA
$50.5B
| $334M | 0.1% |
5,846,625
+2,379
| +0% | +$136K |
|
189
Gerdau
GGB
$6.03B
| $333M | 0.1% |
92,970,762
-18,147,532
| -16% | -$65.1M |
|
190
Estee Lauder
EL
$30.1B
| $333M | 0.1% |
1,543,672
-558
| -0% | -$121K |
|
191
Guardant Health
GH
$6.85B
| $331M | 0.1% |
6,153,909
+576,044
| +10% | +$31M |
|
192
OneMain Financial
OMF
$7.2B
| $328M | 0.1% |
11,094,970
+4,920
| +0% | +$145K |
|
193
Frontier Communications
FYBR
$9.39B
| $327M | 0.1% |
13,948,307
+41,672
| +0.3% | +$976K |
|
194
GSK
GSK
$82.2B
| $326M | 0.1% |
11,066,164
-4,203,987
| -28% | -$124M |
|
195
Dow Inc
DOW
$17.7B
| $326M | 0.1% |
7,410,467
-3,530,600
| -32% | -$155M |
|
196
The Mosaic Company
MOS
$10.7B
| $325M | 0.09% |
6,734,723
+538,293
| +9% | +$26M |
|
197
Blue Owl Capital
OWL
$12.2B
| $325M | 0.09% |
35,195,306
+1,548,393
| +5% | +$14.3M |
|
198
Ecolab
ECL
$77.3B
| $317M | 0.09% |
2,192,426
-216
| -0% | -$31.2K |
|
199
Suncor Energy
SU
$50.6B
| $315M | 0.09% |
11,194,681
-964,266
| -8% | -$27.2M |
|
200
ATI
ATI
$10.5B
| $315M | 0.09% |
11,822,550
+44,941
| +0.4% | +$1.2M |
|